CTCF and Familial prostate cancer: Indeed, we found that promoters, CTCF sites, and enhancers could all exhibit characteristics of epigenetic activation in MCF7 breast cancer cells (Fig. 4A) and in PC3 prostate cancer cells (Fig. 4B).